Skip to content
Send E-mail
623-466-6246
Facebook
Twitter
Youtube
Instagram
Linkedin
Home
About Us
Mission
Meet the Founders
Leadership
CCEP Learning Center
Virtual Cancer Caregivers Education Program ™
A Guide for Cancer Caregivers
Cancer Caregivers Articles and Statistics
Resource Directory
CC Events
Patient and Caregivers Summit Booklet
Partner & Sponsorship Opportunities
CC Stories
CC News
Current Newsletter
Newsletter Archives
Newsletter Signup
Articles
Press
You Can Help
How To Become a Volunteer
Sponsor and/or Give
General Donation
Donation to the Underserved
Honor Wall Donation
Fry’s Community Rewards Program
Amazon Smile Program
Give an In-kind Gift
CC Gallery
Event Gallery
Videos
Honor Wall
Contacts
Menu
Home
About Us
Mission
Meet the Founders
Leadership
CCEP Learning Center
Virtual Cancer Caregivers Education Program ™
A Guide for Cancer Caregivers
Cancer Caregivers Articles and Statistics
Resource Directory
CC Events
Patient and Caregivers Summit Booklet
Partner & Sponsorship Opportunities
CC Stories
CC News
Current Newsletter
Newsletter Archives
Newsletter Signup
Articles
Press
You Can Help
How To Become a Volunteer
Sponsor and/or Give
General Donation
Donation to the Underserved
Honor Wall Donation
Fry’s Community Rewards Program
Amazon Smile Program
Give an In-kind Gift
CC Gallery
Event Gallery
Videos
Honor Wall
Contacts
Donate
Send E-mail
623-466-6246
Facebook
Twitter
Youtube
Instagram
Linkedin
Archives:
Donation Forms
Valentines Day Donation Form
Donation Form – Underserved Population
Honor Wall Donation Form
General Donation Form
1
Step 1
Registration Form
First Name*
Last Name*
Email
email
Mobile Phone
phone
Address*
Country*
- Select
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
City*
State*
Select An Option
Alaska
Alabama
Arkansas
American Samoa
Arizona
California
Colorado
Connecticut
District
of Columbia
Delaware
Florida
Georgia
Guam
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana
North Carolina
North Dakota
Nebraska
New Hampshire
New Jersey
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Virgin Islands
Vermont
Washington
Wisconsin
West Virginia
Wyoming
Zip*
I will be attending the Patient and Caregiver Summit*
Select An Option
I will be attending in person in Scottsdale.
I plan on participating virtually.
If attending in person, how many guests will you be bringing with you?
Select An Option
0
1
2
3
4 or more
My connection to myeloma is (I am a)*
Select An Option
Myeloma Patient
Myeloma Patient Caregiver
Myeloma Patient Family Member (non-caregiver)
Family/Friend of Deceased Myeloma Patient
Health Care Professional or Researcher
Biopharma, Medical Device, or Healthcare Technology Industry Professional
Other: Cancer Caregiver
My current myeloma status/the current myeloma status of the patient I know is:
Select An Option
MGUS/SMM
Newly Diagnosed
Remission/Response
Relapsed/Refractory
Not Sure
Not Applicable to Me
How much do you agree with the following statements? (1 = Strongly disagree; 5 = Strongly agree) I am confident in my ability to interpret blood and bone marrow biopsy test results.
Select An Option
1
2
3
4
5
I know the benefit of getting a second opinion when needed.*
Select An Option
1
2
3
4
5
I am familiar with the implications of high-risk disease and the tests that can define it.*
Select An Option
1
2
3
4
5
I am familiar with the standard of care for my disease subtype.*
Select An Option
1
2
3
4
5
I am aware that a clinical trial may be the best option for me, based on the specific disease subtype I have.*
Select An Option
1
2
3
4
5
I know the information I need to convey to my care team to let them know what my treatment goals are.*
Select An Option
1
2
3
4
5
I am confident in my ability to access information that will support an informed decision about treatment selection for my disease subtype.*
Select An Option
1
2
3
4
5
How did you learn about this program? (Choose all that apply.)
Email invitation
MMRF e-newsletter
CCAZ newsletter
Treatment center
MMRF website
CCAZ Website
Support group
Social media (eg, Facebook, Twitter)
Physician’s office
Word of mouth
Other:
Other: How did you learn about this program?
Submit Form
keyboard_arrow_left
Previous
Next
keyboard_arrow_right
FormCraft - WordPress form builder
